239 related articles for article (PubMed ID: 34561620)
1. Structures of active melanocortin-4 receptor-Gs-protein complexes with NDP-α-MSH and setmelanotide.
Heyder NA; Kleinau G; Speck D; Schmidt A; Paisdzior S; Szczepek M; Bauer B; Koch A; Gallandi M; Kwiatkowski D; Bürger J; Mielke T; Beck-Sickinger AG; Hildebrand PW; Spahn CMT; Hilger D; Schacherl M; Biebermann H; Hilal T; Kühnen P; Kobilka BK; Scheerer P
Cell Res; 2021 Nov; 31(11):1176-1189. PubMed ID: 34561620
[TBL] [Abstract][Full Text] [Related]
2. Structural analysis of setmelanotide binding to MC4R variants in comparison to wild-type receptor.
Hammad MM; Mohammad A; Alam-Eldin N; Madhu D; Al-Mulla F; Abu-Farha M; Abubaker J
Life Sci; 2022 Oct; 307():120857. PubMed ID: 35931197
[TBL] [Abstract][Full Text] [Related]
3. Key amino acid residue in Melanocortin-1 receptor (melanocyte α-MSH receptor) for ligand selectivity.
Yang Y; Chen M; Ventro G; Harmon CM
Mol Cell Endocrinol; 2017 Oct; 454():69-76. PubMed ID: 28579117
[TBL] [Abstract][Full Text] [Related]
4. Interactions of the melanocortin-4 receptor with the peptide agonist NDP-MSH.
Chapman KL; Kinsella GK; Cox A; Donnelly D; Findlay JB
J Mol Biol; 2010 Aug; 401(3):433-50. PubMed ID: 20600126
[TBL] [Abstract][Full Text] [Related]
5. Structure reveals the activation mechanism of the MC4 receptor to initiate satiation signaling.
Israeli H; Degtjarik O; Fierro F; Chunilal V; Gill AK; Roth NJ; Botta J; Prabahar V; Peleg Y; Chan LF; Ben-Zvi D; McCormick PJ; Niv MY; Shalev-Benami M
Science; 2021 May; 372(6544):808-814. PubMed ID: 33858992
[TBL] [Abstract][Full Text] [Related]
6. Substituted NDP-MSH peptides paired with mutant melanocortin-4 receptors demonstrate the role of transmembrane 6 in receptor activation.
Fleck BA; Ling N; Chen C
Biochemistry; 2007 Sep; 46(37):10473-83. PubMed ID: 17713970
[TBL] [Abstract][Full Text] [Related]
7. A Setmelanotide-like Effect at MC4R Is Achieved by MC4R Dimer Separation.
Reininghaus N; Paisdzior S; Höpfner F; Jyrch S; Cetindag C; Scheerer P; Kühnen P; Biebermann H
Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36009013
[TBL] [Abstract][Full Text] [Related]
8. Differential Signaling Profiles of MC4R Mutations with Three Different Ligands.
Paisdzior S; Dimitriou IM; Schöpe PC; Annibale P; Scheerer P; Krude H; Lohse MJ; Biebermann H; Kühnen P
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32059383
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency.
Collet TH; Dubern B; Mokrosinski J; Connors H; Keogh JM; Mendes de Oliveira E; Henning E; Poitou-Bernert C; Oppert JM; Tounian P; Marchelli F; Alili R; Le Beyec J; Pépin D; Lacorte JM; Gottesdiener A; Bounds R; Sharma S; Folster C; Henderson B; O'Rahilly S; Stoner E; Gottesdiener K; Panaro BL; Cone RD; Clément K; Farooqi IS; Van der Ploeg LHT
Mol Metab; 2017 Oct; 6(10):1321-1329. PubMed ID: 29031731
[TBL] [Abstract][Full Text] [Related]
10. Insights into the Allosteric Mechanism of Setmelanotide (RM-493) as a Potent and First-in-Class Melanocortin-4 Receptor (MC4R) Agonist To Treat Rare Genetic Disorders of Obesity through an in Silico Approach.
Falls BA; Zhang Y
ACS Chem Neurosci; 2019 Mar; 10(3):1055-1065. PubMed ID: 30048591
[TBL] [Abstract][Full Text] [Related]
11. Structural insights into ligand recognition and activation of the melanocortin-4 receptor.
Zhang H; Chen LN; Yang D; Mao C; Shen Q; Feng W; Shen DD; Dai A; Xie S; Zhou Y; Qin J; Sun JP; Scharf DH; Hou T; Zhou T; Wang MW; Zhang Y
Cell Res; 2021 Nov; 31(11):1163-1175. PubMed ID: 34433901
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanism of the intracellular segments of the melanocortin-4 receptor for NDP-MSH signaling.
Yang Y; Chen M; Loux TJ; Georgeson KE; Harmon CM
Biochemistry; 2005 May; 44(18):6971-9. PubMed ID: 15865442
[TBL] [Abstract][Full Text] [Related]
13. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
Frändberg PA; Doufexis M; Kapas S; Chhajlani V
Biochem Biophys Res Commun; 2001 Mar; 281(4):851-7. PubMed ID: 11237737
[TBL] [Abstract][Full Text] [Related]
14. Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants.
Haskell-Luevano C; Cone RD; Monck EK; Wan YP
Biochemistry; 2001 May; 40(20):6164-79. PubMed ID: 11352754
[TBL] [Abstract][Full Text] [Related]
15. Molecular determinants of ligand binding to the human melanocortin-4 receptor.
Yang YK; Fong TM; Dickinson CJ; Mao C; Li JY; Tota MR; Mosley R; Van Der Ploeg LH; Gantz I
Biochemistry; 2000 Dec; 39(48):14900-11. PubMed ID: 11101306
[TBL] [Abstract][Full Text] [Related]
16. Molecular cloning, tissue distribution, and pharmacological characterization of melanocortin-4 receptor in spotted scat, Scatophagus argus.
Li JT; Yang Z; Chen HP; Zhu CH; Deng SP; Li GL; Tao YX
Gen Comp Endocrinol; 2016 May; 230-231():143-52. PubMed ID: 27080551
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of 30 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists, synthetic agonists, and the endogenous agouti-related protein antagonist.
Xiang Z; Proneth B; Dirain ML; Litherland SA; Haskell-Luevano C
Biochemistry; 2010 Jun; 49(22):4583-600. PubMed ID: 20462274
[TBL] [Abstract][Full Text] [Related]
18. Structural insight into the MC4R conformational changes via different agonist-mediated receptor signaling.
Yang Y; Chen M; Dimmitt R; Harmon CM
Biochemistry; 2014 Nov; 53(45):7086-92. PubMed ID: 25347793
[TBL] [Abstract][Full Text] [Related]
19. Characterization of melanocortin NDP-MSH agonist peptide fragments at the mouse central and peripheral melanocortin receptors.
Haskell-Luevano C; Holder JR; Monck EK; Bauzo RM
J Med Chem; 2001 Jun; 44(13):2247-52. PubMed ID: 11405661
[TBL] [Abstract][Full Text] [Related]
20. Activation of MAPK by inverse agonists in six naturally occurring constitutively active mutant human melanocortin-4 receptors.
Mo XL; Tao YX
Biochim Biophys Acta; 2013 Dec; 1832(12):1939-48. PubMed ID: 23791567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
